Clinical Pharmacist Interventions in Reducing Cardiovascular Readmission
DOI:
https://doi.org/10.32628/IJSRST251269Keywords:
Clinical pharmacy, Drug-related readmission, Hospital discharge, Pharmacist, Scoping review, Transition of careAbstract
Background: Substantial numbers of hospital readmissions occur due to medication-related problems. Pharmacists can implement different interventions at hospital discharge that aim to reduce those readmissions. It is unclear which pharmacist-led interventions at hospital discharge are the most promising in reducing readmission. Aim: This scoping review aimed to summarize pharmacist-led interventions conducted at hospital discharge that demonstrated a reduction in readmission. Method: We searched the MEDLINE, EMBASE and CINAHL databases up to February 2024. We included studies that focused on pharmacist-led interventions at hospital discharge and reported significant readmission reductions. One reviewer independently screened titles, abstracts and full texts. Data extracted included study characteristics, populations and the type of implemented pharmacist-led interventions along with the reduction in readmission rates achieved. Results: We included 25 articles for data synthesis. Many of the studies included either implemented at least two interventions concurrently or were part of broader programmes involving other healthcare professionals. The most common pharmacist-led interventions associated with reduced readmission rates included medication reconciliation, counselling and post-discharge follow-up by telephone. Follow-up primarily aimed to improve patients' treatment adherence through education about their medications. Furthermore, many studies reported on multi-component interventions that began at hospital admission or during inpatient stays, not only at discharge. Conclusion: Successfully reducing readmission through pharmacist-led interventions at hospital discharge suggests the effectiveness of a holistic approach incorporating multiple interventions. While these findings offer insights for pharmacists, further research should focus on conducting high-quality studies using a multifaceted approach to identify the most appropriate timing and combination. A multi-tiered intervention augmented by clinical pharmacy specialists demonstrates promising results for cost-effective reduction of 30-day HF readmission rates.
📊 Article Downloads
References
Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the medicare fee-for-service program. N Engl J Med. 2009;360(14):1418–28.
Vest JR, Gamm LD, Oxford BA, et al. Determinants of preventable readmissions in the United States: a systematic review. Implement Sci. 2010;5:88.
PCNE Classification for Drug-Related Problems V9.1. Pharmaceutical Care Network Europe Association; 2020.
El Morabet N, Uitvlugt EB, van den Bemt BJF, et al. Prevalence and preventability of drug-related hospital readmissions: a systematic review. J Am Geriatr Soc. 2018;66(3):602–8.
Graabæk T, Terkildsen BG, Lauritsen KE, et al. Frequency of undocumented medication discrepancies in discharge letters after hospitalization of older patients: a clinical record review study.
Parekh N, Ali K, Stevenson JM, et al. Incidence and cost of medication harm in older adults following hospital discharge: a multicentre prospective study in the UK. Br J Clin Pharmacol. 2018;84(8):1789–97. DOI: https://doi.org/10.1111/bcp.13613
Cooper JB, Jeter E, Sessoms CJ. Rates and types of medication-related problems in patients rehospitalized within 30 days of discharge from a community hospital. J Pharm Technol. 2020;36(2):47–53. DOI: https://doi.org/10.1177/8755122519883642
Dalleur O, Beeler PE, Schnipper JL, et al. 30-day potentially avoidable readmissions due to adverse drug events. J Patient Saf. 2021;17(5):e379–86. DOI: https://doi.org/10.1097/PTS.0000000000000346
Uitvlugt EB, Janssen MJA, Siegert CEH, et al. Medication-related hospital readmissions within 30 days of discharge: prevalence, preventability, type of medication errors and risk factors. Front Pharmacol. 2021;12: 567424. DOI: https://doi.org/10.3389/fphar.2021.567424
Whitaker AS, Cottrell WN. What proportion of unplanned re-presentations to an emergency department are medication related and preventable? J Pharm Pract Res. 2019;49(6):546–56. DOI: https://doi.org/10.1002/jppr.1581
Linkens A, Milosevic V, van der Kuy PHM, et al. Medication-related hospital admissions and readmissions in older patients: an overview of literature. Int J Clin Pharm. 2020;42(5):1243–51. DOI: https://doi.org/10.1007/s11096-020-01040-1
Schönenberger N, Blanc AL, Hug BL, et al. Developing indicators for medication-related readmissions based on a Delphi consensus study. Res Social Adm Pharm. 2024;20(6):92–101. DOI: https://doi.org/10.1016/j.sapharm.2024.02.012
Kripalani S, Roumie CL, Dalal AK, et al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157(1):1–10. DOI: https://doi.org/10.7326/0003-4819-157-1-201207030-00003
Walker PC, Bernstein SJ, Jones JNT, et al. Impact of a pharmacist-facilitated hospital discharge program: a quasi-experimental study. Arch Intern Med. 2009;169(21):2003–10. DOI: https://doi.org/10.1001/archinternmed.2009.398
Miller D, Ramsey M, L’Hommedieu TR, et al. Pharmacist-led transitions-of-care program reduces 30-day readmission rates for Medicare patients in a large health system. Am J Health Syst Pharm. 2020;77(12):972–8. DOI: https://doi.org/10.1093/ajhp/zxaa071
Kelly WN, Ho M-J, Bullers K, et al. Association of pharmacist counseling with adherence, 30-day readmission, and mortality: a systematic review and meta-analysis of randomized trials. J Am Pharm Assoc. 2021;61(3):340. DOI: https://doi.org/10.1016/j.japh.2021.01.028
Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6(2): e010003. DOI: https://doi.org/10.1136/bmjopen-2015-010003
March KL, Peters MJ, Finch CK, et al. Pharmacist transition-of-care services improve patient satisfaction and decrease hospital readmissions. J Pharm Pract. 2022;35(1):86–93. DOI: https://doi.org/10.1177/0897190020958264
Farley TM, Shelsky C, Powell S, et al. Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge. Int J Clin Pharm. 2014;36(2):430–7. DOI: https://doi.org/10.1007/s11096-014-9917-x
Al-Hashar A, Al-Zakwani I, Eriksson T, et al. Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use. Int J Clin Pharm. 2018;40(5):1154–64. DOI: https://doi.org/10.1007/s11096-018-0650-8
Odeh M, Scullin C, Fleming G, et al. Ensuring continuity of patient care across the healthcare interface: telephone follow-up post-hospitalization. Br J Clin Pharmacol. 2019;85(3):616–25. DOI: https://doi.org/10.1111/bcp.13839
Witherington EMA, Pirzada OM, Avery AJ. Communication gaps and readmissions to hospital for patients aged 75 years and older: observational study. Qual Saf Health Care. 2008;17(1):71–5. DOI: https://doi.org/10.1136/qshc.2006.020842
Bülow C, Clausen SS, Lundh A, et al. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2023;1(1):Cd008986. DOI: https://doi.org/10.1002/14651858.CD008986.pub4
Daliri S, Boujarfi S, el Mokaddam A, et al. Medication-related interventions delivered both in hospital and following discharge: a systematic review and meta-analysis. BMJ Qual Saf. 2021;30(2):146–56. DOI: https://doi.org/10.1136/bmjqs-2020-010927
Gillespie U, Alassaad A, Henrohn D, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169(9):894–900. DOI: https://doi.org/10.1001/archinternmed.2009.71
Ravn-Nielsen LV, Duckert M-L, Lund ML, et al. Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial. JAMA Intern Med. 2018;178(3):375–82. DOI: https://doi.org/10.1001/jamainternmed.2017.8274
Gurwitz JH, Kapoor A, Garber L, et al. Effect of a multifaceted clinical pharmacist intervention on medication safety after hospitalization in persons prescribed high-risk medications: a randomized clinical trial. JAMA Intern Med. 2021;181(5):610–8. DOI: https://doi.org/10.1001/jamainternmed.2020.9285
Kempen TGH, Bertilsson M, Hadziosmanovic N, et al. Effects of hospital-based comprehensive medication reviews including postdischarge follow-up on older patients’ use of health care: a cluster randomized clinical trial. JAMA Netw Open. 2021;4(4):e216303. DOI: https://doi.org/10.1001/jamanetworkopen.2021.6303
Harris M, Moore V, Barnes M, et al. Effect of pharmacy-led interventions during care transitions on patient hospital readmission: a systematic review. J Am Pharm Assoc (2003). 2022;62(5):1477. DOI: https://doi.org/10.1016/j.japh.2022.05.017
Rodrigues CR, Harrington AR, Murdock N, et al. Effect of pharmacy-supported transition-of-care interventions on 30-day readmissions: a systematic review and meta-analysis. Ann Pharmacother. 2017;51(10):866–89. DOI: https://doi.org/10.1177/1060028017712725
Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73. DOI: https://doi.org/10.7326/M18-0850
Lazaridis D, Partosh D, Ricabal LC, et al. Impact of a centralized population health pharmacy program on value-based Medicare patients 2003. J Am Pharm Assoc. 2024;64(1):146–53. DOI: https://doi.org/10.1016/j.japh.2023.09.008
Gallagher D, Greenland M, Lindquist D, et al. Inpatient pharmacists using a readmission risk model in supporting discharge medication reconciliation to reduce unplanned hospital readmissions: a quality improvement intervention. BMJ Open Qual. 2022;11(1):e001560. DOI: https://doi.org/10.1136/bmjoq-2021-001560
Fosnight S, King P, Ewald J, et al. Effects of pharmacy interventions at transitions of care on patient outcomes. Am J Health Syst Pharm. 2020;77(12):943–9. DOI: https://doi.org/10.1093/ajhp/zxaa081
Lam SW, Sokn E. Effect of pharmacy-driven bedside discharge medication delivery program on day 30 hospital readmission. J Pharm Pract. 2020;33(5):628–32. DOI: https://doi.org/10.1177/0897190019825961
McConachie SM, Raub JN, Yost R, et al. Evaluation of a multidisciplinary approach to reduce internal medicine readmissions using a readmission prediction index. Am J Health Syst Pharm. 2020;77(12):950–7. DOI: https://doi.org/10.1093/ajhp/zxaa078
Chiu P, Lee A, See T, et al. Outcomes of a pharmacist-led medication review programme for hospitalised elderly patients. Hong Kong Med J. 2018;24(2):98–106.
Rottman-Sagebiel R, Cupples N, Wang CP, et al. A pharmacist-led transitional care program to reduce hospital readmissions in older adults. Fed Pract. 2018;35(12):42–50.
Shanika LGT, Jayamanne S, Wijekoon CN, et al. Ward-based clinical pharmacists and hospital readmission: a non-randomized controlled trial in Sri Lanka. Bull World Health Organ. 2018;96(3):155–64. DOI: https://doi.org/10.2471/BLT.17.198366
Phatak A, Prusi R, Ward B, et al. Impact of pharmacist involvement in the transitional care of high-risk patients through medication reconciliation, medication education, and postdischarge call-backs. J Hosp Med. 2016;11(1):39–44. DOI: https://doi.org/10.1002/jhm.2493
Rafferty A, Denslow S, Michalets EL. Pharmacist-provided medication management in interdisciplinary transitions in a community hospital (PMIT). Ann Pharmacother. 2016;50(8):649–55. DOI: https://doi.org/10.1177/1060028016653139
Zemaitis CT, Morris G, Cabie M, et al. Reducing readmission at an academic medical center: results of a pharmacy-facilitated discharge counseling and medication reconciliation program. Hosp Pharm. 2016;51(6):468–73. DOI: https://doi.org/10.1310/hpj5106-468
Balling L, Erstad BL, Weibel K. Impact of a transition-of-care pharmacist during hospital discharge 2003. J Am Pharm Assoc. 2015;55(4):443–8. DOI: https://doi.org/10.1331/JAPhA.2015.14087
Sanchez GM, Douglass MA, Mancuso MA. Revisiting project re-engineered discharge (red): the impact of a pharmacist telephone intervention on hospital readmission rates. Pharmacotherapy. 2015;35(9):805–12. DOI: https://doi.org/10.1002/phar.1630
Hutchison LJ, Mayzell GG, Bailey SC, et al. Impact of a discharge medication therapy management program in an extended care hospital. Consult Pharm. 2014;29(1):33–8.Pal A, Babbott S, Wilkinson ST. Can the targeted use of a discharge pharmacist significantly decrease 30-day readmissions? Hosp Pharm. 2013;48(5):380–8. DOI: https://doi.org/10.1310/hpj4805-380
Gardella JE, Cardwell TB, Nnadi M. Improving medication safety with accurate preadmission medication lists and postdischarge education. Jt Comm J Qual Patient Saf. 2012;38(10):452–8.Sanchez Ulayar A, Gallardo Lopez S, Pons Llobet N, et al. Pharmaceutical intervention upon hospital discharge to strengthen understanding and adherence to pharmacological treatment. Farm Hosp. 2012;36(3):118–23. DOI: https://doi.org/10.1016/S1553-7250(12)38060-4
Jack BW, Chetty VK, Anthony D, et al.A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med. 2009;150(3):178–87. DOI: https://doi.org/10.7326/0003-4819-150-3-200902030-00007
Koehler BE, Richter KM, Youngblood L, et al. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle. J Hosp Med. 2009;4(4):211–8. DOI: https://doi.org/10.1002/jhm.427
Scullin C, Scott MG, Hogg A, et al. An innovative approach to integrated medicines management. J Eval Clin Pract. 2007;13(5):781–8. DOI: https://doi.org/10.1111/j.1365-2753.2006.00753.x
Crotty M, Rowett D, Spurling L, et al. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? results of a randomized, controlled trial. Am J Geriatr Pharmacother. 2004;2(4):257–64. DOI: https://doi.org/10.1016/j.amjopharm.2005.01.001
Al-Rashed SA, Wright DJ, Roebuck N, et al. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol. 2002;54(6):657–64. DOI: https://doi.org/10.1046/j.1365-2125.2002.01707.x
Ensing HT, Stuijt CCM, van den Bemt BJF, et al. Identifying the optimal role for pharmacists in care transitions: a systematic review. J Manag Care Spec Pharm. 2015;21(8):614–38. DOI: https://doi.org/10.18553/jmcp.2015.21.8.614
Becker C, Zumbrunn S, Beck K, et al. Interventions to improve communication at hospital discharge and rates of readmission: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(8):e2119346. DOI: https://doi.org/10.1001/jamanetworkopen.2021.19346
Coffey A, Leahy-Warren P, Savage E, et al. Interventions to promote early discharge and avoid inappropriate hospital (re)admission: a systematic review. Int J Environ Res Public Health. 2019;16(14):2457. DOI: https://doi.org/10.3390/ijerph16142457
Bonetti AF, Bagatim BQ, Mendes AM, et al. Impact of discharge medication counseling in the cardiology unit of a tertiary hospital in Brazil: a randomized controlled trial. Clinics (Sao Paulo). 2018;73: e325. DOI: https://doi.org/10.6061/clinics/2018/e325
Marusic S, Gojo-Tomic N, Erdeljic V, et al. The effect of pharmacotherapeutic counseling on readmissions and emergency department visits. Int J Clin pharma 2013;35(1):37–44. DOI: https://doi.org/10.1007/s11096-012-9700-9
Schönenberger N, Meyer-Massetti C. Risk factors for medication-related short-term readmissions in adults – a scoping review. BMC Health Serv Res. 2023;23(1):1037. DOI: https://doi.org/10.1186/s12913-023-10028-2
Marsall M, Hornung T, Bäuerle A, et al. Quality of care transition, patient safety incidents, and patients’ health status: a structural equation model on the complexity of the discharge process. BMC Health Serv Res. 2024;24(1):576. DOI: https://doi.org/10.1186/s12913-024-11047-3
Weber C et al. Pharmacist-led interventions at hospital discharge: a scoping review of studies demonstrating reduced readmission rates. Int J Clin Pharm. 2025 Feb;47(1):15-30. doi: 10.1007/s11096-024-01821-y. DOI: https://doi.org/10.1007/s11096-024-01821-y
Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the medicare fee-for-service program. N Engl J Med. 2009;360(14):1418–28. - PubMed DOI: https://doi.org/10.1056/NEJMsa0803563
Vest JR, Gamm LD, Oxford BA, et al. Determinants of preventable readmissions in the United States: a systematic review. Implement Sci. 2010;5:88. - PMC - PubMed DOI: https://doi.org/10.1186/1748-5908-5-88
PCNE Classification for Drug-Related Problems V9.1. Pharmaceutical Care Network Europe Association; 2020. Available at: https://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf. Accessed May 2020.
El Morabet N, Uitvlugt EB, van den Bemt BJF, et al. Prevalence and preventability of drug-related hospital readmissions: a systematic review. J Am Geriatr Soc. 2018;66(3):602–8. - PubMed DOI: https://doi.org/10.1111/jgs.15244
Graabæk T, Terkildsen BG, Lauritsen KE, et al. Frequency of undocumented medication discrepancies in discharge letters after hospitalization of older patients: a clinical record review study. Ther Adv Drug Saf. 2019;10:2042098619858049. - PMC - PubMed DOI: https://doi.org/10.1177/2042098619858049
Benge, C, Diedrich, L, Young, E. et al. POSITIVE IMPACT OF A CLINICAL PHARMACY SPECIALIST-BASED INTERVENTION PROGRAM ON HEART FAILURE READMISSION RATES. JACC. 2019 Mar, 73 (9_Supplement_1) 2140. DOI: https://doi.org/10.1016/S0735-1097(19)32746-9
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Scientific Research in Science and Technology
This work is licensed under a Creative Commons Attribution 4.0 International License.
https://creativecommons.org/licenses/by/4.0
